$BCRX
BIOCRYST PHARMACEUTICALS INC

2014 Q1 Form 10-K Financial Statement

#000119312514091609 Filed on March 10, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q4 2013 Q3
Revenue $3.458M $10.57M $2.389M
YoY Change -2.7% 157.67% -58.53%
Cost Of Revenue $70.00K $20.00K $0.00
YoY Change -12.5% 0.0% -100.0%
Gross Profit $3.390M $10.55M $2.390M
YoY Change -2.59% 158.58% -57.7%
Gross Profit Margin 98.03% 99.84% 100.04%
Selling, General & Admin $1.590M $2.060M $1.340M
YoY Change 15.22% 6.74% -15.72%
% of Gross Profit 46.9% 19.53% 56.07%
Research & Development $9.183M $14.83M $7.977M
YoY Change 27.28% 33.72% -33.92%
% of Gross Profit 270.88% 140.57% 333.77%
Depreciation & Amortization $53.00K $50.00K $70.00K
YoY Change -45.36% -70.59% -46.15%
% of Gross Profit 1.56% 0.47% 2.93%
Operating Expenses $9.183M $16.88M $7.977M
YoY Change 27.28% 29.65% -33.92%
Operating Profit -$7.386M -$6.330M -$6.925M
YoY Change 38.94% -29.19% -13.61%
Interest Expense $1.242M $910.0K $1.191M
YoY Change 5.25% -352.78% 2.14%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$10.14M -$5.430M -$8.000M
YoY Change 124.83% -50.86% -17.53%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$10.14M -$5.429M -$8.001M
YoY Change 124.97% -50.88% -17.52%
Net Earnings / Revenue -293.15% -51.38% -334.91%
Basic Earnings Per Share
Diluted Earnings Per Share -$170.2K -$91.83K -$140.1K
COMMON SHARES
Basic Shares Outstanding 59.38M shares 59.09M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q1 2013 Q4 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $31.39M $38.06M $42.59M
YoY Change 10.92% 6.9% 3.88%
Cash & Equivalents $13.58M $21.16M $26.05M
Short-Term Investments $17.81M $16.89M $16.54M
Other Short-Term Assets $1.000M $1.900M $1.900M
YoY Change -64.29% 5.56% 26.67%
Inventory
Prepaid Expenses
Receivables $3.300M $2.100M $2.400M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $35.73M $42.12M $46.84M
YoY Change 0.94% 0.34% 0.51%
LONG-TERM ASSETS
Property, Plant & Equipment $260.0K $306.0K $359.0K
YoY Change -48.0% -47.51% -55.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.700M $2.600M $700.0K
YoY Change 116.67% -72.0%
Other Assets $4.495M $3.620M $5.075M
YoY Change -59.14% -58.36% -64.26%
Total Long-Term Assets $7.656M $6.745M $6.366M
YoY Change -33.43% -56.37% -63.62%
TOTAL ASSETS
Total Short-Term Assets $35.73M $42.12M $46.84M
Total Long-Term Assets $7.656M $6.745M $6.366M
Total Assets $43.39M $48.87M $53.21M
YoY Change -7.49% -14.93% -17.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.352M $4.174M $1.241M
YoY Change 22.91% 5.03% -46.04%
Accrued Expenses $6.312M $5.742M $7.668M
YoY Change -27.45% -41.76% -14.8%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.69M $15.26M $13.18M
YoY Change 21.14% -11.43% 4.62%
LONG-TERM LIABILITIES
Long-Term Debt $30.00M $30.00M $30.00M
YoY Change 0.0% 0.0% 0.0%
Other Long-Term Liabilities $5.400M $4.700M $6.600M
YoY Change -35.71% -56.07% -43.59%
Total Long-Term Liabilities $35.40M $34.70M $36.60M
YoY Change -7.81% -14.74% -12.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.69M $15.26M $13.18M
Total Long-Term Liabilities $35.40M $34.70M $36.60M
Total Liabilities $49.10M $50.00M $49.80M
YoY Change -1.21% -13.64% -8.29%
SHAREHOLDERS EQUITY
Retained Earnings -$432.8M -$422.7M -$417.3M
YoY Change 7.67%
Common Stock $427.1M $421.6M $420.7M
YoY Change 7.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.723M -$1.126M $3.410M
YoY Change
Total Liabilities & Shareholders Equity $43.39M $48.87M $53.21M
YoY Change -7.49% -14.93% -17.0%

Cashflow Statement

Concept 2014 Q1 2013 Q4 2013 Q3
OPERATING ACTIVITIES
Net Income -$10.14M -$5.429M -$8.001M
YoY Change 124.97% -50.88% -17.52%
Depreciation, Depletion And Amortization $53.00K $50.00K $70.00K
YoY Change -45.36% -70.59% -46.15%
Cash From Operating Activities -$8.959M -$4.510M -$7.930M
YoY Change -19.99% -35.85% -32.68%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K $0.00 $0.00
YoY Change -100.0% -100.0%
Acquisitions
YoY Change
Other Investing Activities -$1.020M -$2.260M -$5.810M
YoY Change -149.28% -161.92% -149.74%
Cash From Investing Activities -$1.023M -$2.260M -$5.810M
YoY Change -149.37% -162.09% -149.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $18.50M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.402M 1.890M 20.01M
YoY Change -20.99% 490.62% 839.44%
NET CHANGE
Cash From Operating Activities -8.959M -4.510M -7.930M
Cash From Investing Activities -1.023M -2.260M -5.810M
Cash From Financing Activities 2.402M 1.890M 20.01M
Net Change In Cash -7.580M -4.880M 6.270M
YoY Change 24.55% 58.96% 208.87%
FREE CASH FLOW
Cash From Operating Activities -$8.959M -$4.510M -$7.930M
Capital Expenditures -$10.00K $0.00 $0.00
Free Cash Flow -$8.949M -$4.510M -$7.930M
YoY Change -20.08% -35.94% -32.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
59384525 shares
CY2012Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
5.23
CY2012Q1 bcrx Annual Incentive Earned
AnnualIncentiveEarned
1542000
CY2011Q2 us-gaap Common Stock Value
CommonStockValue
70000000
CY2011Q3 bcrx Common Stock Issued And Sales At Market Price
CommonStockIssuedAndSalesAtMarketPrice
70000000
CY2013Q2 dei Entity Public Float
EntityPublicFloat
83060095
CY2013Q3 us-gaap Share Price
SharePrice
4.40
CY2013Q3 bcrx Net Proceeds From Public Offering
NetProceedsFromPublicOffering
18500000
CY2013Q3 bcrx Deduction In Interest
DeductionInInterest
2356
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.66
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6802000 shares
CY2010Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1858000 shares
CY2010Q4 us-gaap Restructuring Reserve
RestructuringReserve
158000
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
65503000
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13622000
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
190000 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.21
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7858000 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2009000 shares
CY2011Q4 us-gaap Restructuring Reserve
RestructuringReserve
CY2011Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
14806000
CY2011Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16444000
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50893000 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
350000 shares
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-454000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
391611000
CY2012Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
14708000
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
158989000
CY2012Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
263000
CY2012Q4 us-gaap Assets
Assets
57439000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20891000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50893000 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
4.08
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.09
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8073000 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2815000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9860000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14349000
CY2012Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3974000
CY2012Q4 us-gaap Restructuring Reserve
RestructuringReserve
1701000
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
158989000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
17224000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
27000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
CY2012Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2012Q4 us-gaap Foreign Currency Derivative Liabilities At Fair Value
ForeignCurrencyDerivativeLiabilitiesAtFairValue
4749000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-392601000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1392000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
509000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
57439000
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4243000
CY2012Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
30000000
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
5920000
CY2012Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1998000
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
14708000
CY2012Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
4562000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
41978000
CY2012Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
1151000
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
15775000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
6475000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8694000
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
308000
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
108498000
CY2012Q4 us-gaap Deferred Tax Assets Unrealized Currency Losses
DeferredTaxAssetsUnrealizedCurrencyLosses
1851000
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2012Q4 us-gaap Inventory Net
InventoryNet
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
1654000
CY2012Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
1185000
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14932000
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
36142000
CY2012Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
2645000
CY2012Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
15859000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1097000
CY2012Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
412000
CY2012Q4 us-gaap Investments And Cash
InvestmentsAndCash
40788000
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
539000
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3980000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
583000
CY2012Q4 bcrx Currency Hedge Agreement Amount
CurrencyHedgeAgreementAmount
5180000
CY2012Q4 bcrx Deferred Collaboration Expense Assets
DeferredCollaborationExpenseAssets
5033000
CY2012Q4 bcrx Available For Sale Securities Accrued Interest
AvailableForSaleSecuritiesAccruedInterest
57000
CY2012Q4 bcrx Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
6573000
CY2012Q4 bcrx Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
1151000
CY2012Q4 bcrx Cash Collateral Margin Funds
CashCollateralMarginFunds
5180000
CY2012Q4 bcrx Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
CY2012Q4 bcrx Available For Sale Securities Debt Maturities After Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTwoYearsFairValue
CY2012Q4 bcrx Available For Sale Securities Gross Unrealized Gains Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainsAccumulatedInInvestments
27000
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59092000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
563000 shares
CY2013Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
8986000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59092000 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased
ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased
1.85
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.99
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8986000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
1082000 shares
CY2013Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
6.20
CY2013Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
4.99
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
4777000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5742000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
367000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14108000
CY2013Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1415000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4174000
CY2013Q4 us-gaap Restructuring Reserve
RestructuringReserve
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
167556000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15256000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
284000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-1126000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
420988000
CY2013Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-422709000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1473000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
591000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48866000
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
4243000
CY2013Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
30000000
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4736000
CY2013Q4 us-gaap Interest Payable Current
InterestPayableCurrent
3867000
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1048000
CY2013Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
16891000
CY2013Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
2115000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
42121000
CY2013Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
2582000
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
19421000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
5282000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3620000
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
151000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
119940000
CY2013Q4 us-gaap Deferred Tax Assets Unrealized Currency Losses
DeferredTaxAssetsUnrealizedCurrencyLosses
-207000
CY2013Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
16891000
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
167556000
CY2013Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
263000
CY2013Q4 us-gaap Assets
Assets
48866000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21164000
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2013Q4 us-gaap Inventory Net
InventoryNet
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
1612000
CY2013Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
1119000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
14414000
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
37348000
CY2013Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
2151000
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
19473000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1725000
CY2013Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
75000
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4749000
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
311000
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3980000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
306000
CY2013Q4 bcrx Currency Hedge Agreement Amount
CurrencyHedgeAgreementAmount
0
CY2013Q4 bcrx Deferred Collaboration Expense Assets
DeferredCollaborationExpenseAssets
237000
CY2013Q4 bcrx Available For Sale Securities Accrued Interest
AvailableForSaleSecuritiesAccruedInterest
48000
CY2013Q4 bcrx Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
2210000
CY2013Q4 bcrx Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
2582000
CY2013Q4 bcrx Cash Collateral Margin Funds
CashCollateralMarginFunds
0
CY2013Q4 bcrx Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
1000
CY2013Q4 bcrx Available For Sale Securities Debt Maturities After Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTwoYearsFairValue
CY2013Q4 bcrx Available For Sale Securities Gross Unrealized Gains Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainsAccumulatedInInvestments
5000
CY2013Q4 bcrx Maximum Amount Of Collateral Required To Post
MaximumAmountOfCollateralRequiredToPost
13650000
CY2011Q4 bcrx Percentage Reduction In Royalty Under Amended License Agreement
PercentageReductionInRoyaltyUnderAmendedLicenseAgreement
0.5 pure
CY2012Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
535000
CY2011Q2 us-gaap Retail Land Sale Receivables Weighted Average Interest Rate
RetailLandSaleReceivablesWeightedAverageInterestRate
0.02 pure
CY2010Q2 bcrx Reduction In Percentage Of Future Payments
ReductionInPercentageOfFuturePayments
0.5 pure
CY2013Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4600000 shares
CY2013Q3 bcrx Stock Issued During Period Shares For Over Allotment Option Exercised By Underwriter
StockIssuedDuringPeriodSharesForOverAllotmentOptionExercisedByUnderwriter
600000 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
8000 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
211000 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.022 pure
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.80 pure
CY2011 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.99
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1830000 shares
CY2011 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M0D
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.97
CY2011 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
12000 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.64
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-32251000
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.26
CY2011 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
94000 shares
CY2011 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.57
CY2011 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
184000 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
584000 shares
CY2011 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1003000 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Other Share Increase Decrease
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease
1600000 shares
CY2011 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
437000 shares
CY2011 us-gaap Revenues
Revenues
19643000
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-626000
CY2011 us-gaap Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
158000
CY2011 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-57013000
CY2011 us-gaap Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
-4000000
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
278000
CY2011 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
45500000
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-49587000
CY2011 us-gaap Interest And Other Income
InterestAndOtherIncome
413000
CY2011 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
-2108000
CY2011 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-24396000
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-56948000
CY2011 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-635000
CY2011 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-65000
CY2011 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
300000
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4772000
CY2011 us-gaap Royalty Revenue
RoyaltyRevenue
CY2011 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
61000
CY2011 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-4000000
CY2011 us-gaap Sales Revenue Net
SalesRevenueNet
19643000
CY2011 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1027000
CY2011 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
55000
CY2011 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-65000
CY2011 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-10731000
CY2011 us-gaap Costs And Expenses
CostsAndExpenses
69230000
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11981000
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23755000
CY2011 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
22538000
CY2011 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
300000
CY2011 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1552000
CY2011 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
4772000
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
4772000
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2822000
CY2011 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
714000
CY2011 us-gaap Interest Expense
InterestExpense
3774000
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1027000
CY2011 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-19932000
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11318000
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
57249000
CY2011 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
278000
CY2011 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
886000
CY2011 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
356000
CY2011 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
56873000
CY2011 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-2500000
CY2011 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
731000
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2011 bcrx Weighted Average Shares Outstanding
WeightedAverageSharesOutstanding
45144000 shares
CY2011 bcrx Share Based Compensation Arrangement By Share Based Payment Award Restricted Options Cancelled Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedOptionsCancelledOutstanding
shares
CY2011 bcrx Income Tax Reconciliation Income Tax Expense Benefit For Permanent Items
IncomeTaxReconciliationIncomeTaxExpenseBenefitForPermanentItems
890000
CY2011 bcrx Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Awards Available
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodAwardsAvailable
584000 shares
CY2011 bcrx Share Based Compensation Arrangement By Share Based Payment Award Option Exercised Award Available
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisedAwardAvailable
shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.007 pure
CY2011 bcrx Share Based Compensation Arrangement By Share Based Payment Award Restricted Options Granted Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedOptionsGrantedOutstanding
shares
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0000882796
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2011 bcrx Share Based Compensation Arrangement By Share Based Payment Award Restricted Options Cancelled Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedOptionsCancelledWeightedAverageExercisePrice
CY2011 bcrx Share Based Compensation Arrangement By Share Based Payment Award Restricted Options Granted Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedOptionsGrantedWeightedAverageExercisePrice
CY2011 bcrx Collaborative And Other Research And Development
CollaborativeAndOtherResearchAndDevelopment
19643000
CY2011 bcrx Defined Contribution Plan Employer Matching Contribution Amount
DefinedContributionPlanEmployerMatchingContributionAmount
391000
CY2011 bcrx Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Awards Available
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAwardsAvailable
1830000 shares
CY2011 bcrx Adjustments To Additional Paid In Capital Treasury Stock Purchase
AdjustmentsToAdditionalPaidInCapitalTreasuryStockPurchase
61000
CY2011 bcrx Deferred Collaboration Expense Changes In Operating Assets And Liabilities
DeferredCollaborationExpenseChangesInOperatingAssetsAndLiabilities
-1309000
CY2011 bcrx Issuance Of Non Recourse Notes Payable
IssuanceOfNonRecourseNotesPayable
25691000
CY2011 bcrx Income Tax Reconciliation Income Tax Expense Benefit Expiration Of Carryforwards
IncomeTaxReconciliationIncomeTaxExpenseBenefitExpirationOfCarryforwards
2884000
CY2011 bcrx Income Tax Reconciliation State And Local Income Taxes Net Of Federal Tax Benefit
IncomeTaxReconciliationStateAndLocalIncomeTaxesNetOfFederalTaxBenefit
-2503000
CY2011 bcrx Proceeds From Payments For Foreign Currency Derivative Collateral
ProceedsFromPaymentsForForeignCurrencyDerivativeCollateral
-3480000
CY2013 dei Entity Registrant Name
EntityRegistrantName
BIOCRYST PHARMACEUTICALS INC
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
53000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
310000 shares
CY2013 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P6Y8M12D
CY2013 us-gaap Debt Instrument Date Of First Required Payment1
DebtInstrumentDateOfFirstRequiredPayment1
2011-09-01
CY2013 us-gaap Royalty Revenue
RoyaltyRevenue
2562000
CY2013 us-gaap Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions
4474000
CY2013 us-gaap Payments For Restructuring
PaymentsForRestructuring
1604000
CY2013 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
5294000
CY2013 us-gaap Sales Revenue Net
SalesRevenueNet
17331000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.84 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.22
CY2013 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
47000
CY2013 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-2447000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-30108000
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-23000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
3277000 shares
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y8M12D
CY2013 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
124000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4368000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.05
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
563000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.28
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26530000
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.55
CY2013 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
89000 shares
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.37
CY2013 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 2%; MARGIN-TOP: 18pt"> <b><i>Credit Risk</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Cash equivalents and investments are financial instruments which potentially subject the Company to concentration of risk to the extent recorded on the Consolidated Balance Sheets. The Company deposits excess cash with major financial institutions in the United States. Balances may exceed the amount of insurance provided on such deposits. The Company believes it has established guidelines for investment of its excess cash relative to diversification and maturities that maintain safety and liquidity. To minimize the exposure due to adverse shifts in interest rates, the Company maintains a portfolio of investments with an average maturity of approximately 24 months or less. This majority of the Company&#x2019;s receivables are due from the U.S. Government, for which there is no assumed credit risk.</p> </div>
CY2013 us-gaap Property Plant And Equipment Depreciation Methods
PropertyPlantAndEquipmentDepreciationMethods
Depreciation is computed using the straight-line method with estimated useful lives of five and seven years.
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1801000 shares
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2109000 shares
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-LEFT: 2%; MARGIN-TOP: 18pt"> <b><i>Use of Estimates</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States (&#x201C;U.S. GAAP&#x201D;) requires the Company to make estimates and assumptions that affect the amounts reported in the financial statements. Actual results could differ from those estimates.</p> </div>
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
8567000
CY2013 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
124000
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1103000
CY2013 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
4368000
CY2013 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7547000 shares
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
241000
CY2013 us-gaap Revenues
Revenues
17331000
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
620000
CY2013 us-gaap Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
97000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
43000
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30131000
CY2013 us-gaap Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
5294000
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1333000
CY2013 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
23974000
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-30717000
CY2013 us-gaap Interest And Other Income
InterestAndOtherIncome
93000
CY2013 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
-1206000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
4368000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
273000
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
526000
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
23634000
CY2013 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
30000
CY2013 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-157000
CY2013 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-23000
CY2013 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
5218000
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2049000
CY2013 us-gaap Costs And Expenses
CostsAndExpenses
48048000
CY2013 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5220000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30270000
CY2013 us-gaap Interest Expense
InterestExpense
4778000
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
23633000
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-10538000
CY2013 us-gaap Royalty Expense
RoyaltyExpense
98000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3467000
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
42730000
CY2013 us-gaap Proceeds From Sale Of Furniture And Fixtures
ProceedsFromSaleOfFurnitureAndFixtures
50000
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1333000
CY2013 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
304000
CY2013 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
439000
CY2013 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
20330000
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0
CY2013 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
1892000
CY2013 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1144000
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2013 bcrx Share Based Compensation Arrangement By Share Based Payment Award Restricted Options Cancelled Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedOptionsCancelledWeightedAverageExercisePrice
CY2013 bcrx Share Based Compensation Arrangement By Share Based Payment Award Restricted Options Granted Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedOptionsGrantedWeightedAverageExercisePrice
CY2013 bcrx Yen Rate Per Dollar
YenRatePerDollar
100 JPY
CY2013 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Three
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearThree
580000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000 pure
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37397000
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.79
CY2013 bcrx Weighted Average Shares Outstanding
WeightedAverageSharesOutstanding
55216000 shares
CY2012 us-gaap Revenues
Revenues
26293000
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
623000
CY2012 us-gaap Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
-1759000
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-39094000
CY2013 bcrx Number Of Stock Based Compensation Plan
NumberOfStockBasedCompensationPlan
2 Plan
CY2013 bcrx Foreign Currency Hedge Termination Fee
ForeignCurrencyHedgeTerminationFee
1950000
CY2013 bcrx Redemption In Percentage Year One
RedemptionInPercentageYearOne
1.035 pure
CY2013 bcrx Share Based Compensation Arrangement By Share Based Payment Award Restricted Options Cancelled Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedOptionsCancelledOutstanding
shares
CY2013 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Four
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearFour
114000
CY2013 bcrx Income Tax Reconciliation Income Tax Expense Benefit For Permanent Items
IncomeTaxReconciliationIncomeTaxExpenseBenefitForPermanentItems
738000
CY2013 bcrx Currency Hedge Premium Payable Period Minimum
CurrencyHedgePremiumPayablePeriodMinimum
2014
CY2013 bcrx Long Term Investment Maturity Minimum
LongTermInvestmentMaturityMinimum
P12M
CY2013 bcrx Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Awards Available
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodAwardsAvailable
1801000 shares
CY2013 bcrx Currency Hedge Premium Payable Period Maximum
CurrencyHedgePremiumPayablePeriodMaximum
2020
CY2013 bcrx Share Based Compensation Arrangement By Share Based Payment Award Option Exercised Award Available
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisedAwardAvailable
shares
CY2013 bcrx Share Based Compensation Arrangement By Share Based Payment Award First Vesting Period After Grant Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardFirstVestingPeriodAfterGrantDate
P1Y
CY2013 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year One
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearOne
2609000
CY2013 bcrx Currency Hedge Agreement Termination Period Minimum
CurrencyHedgeAgreementTerminationPeriodMinimum
2016
CY2013 bcrx Foreign Currency Hedge Contingent Payment
ForeignCurrencyHedgeContingentPayment
1950000
CY2013 bcrx Unrecognized Tax Benefits Change Period
UnrecognizedTaxBenefitsChangePeriod
P12M
CY2013 bcrx Minimum Currency Value Required For Payment Of Premium On Specified Date
MinimumCurrencyValueRequiredForPaymentOfPremiumOnSpecifiedDate
100000
CY2013 bcrx Collaborative And Other Research And Development
CollaborativeAndOtherResearchAndDevelopment
14769000
CY2013 bcrx Employee Service Share Based Compensation Nonvested Awards Compensation Cost Expected To Be Recognized Year Two
EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostExpectedToBeRecognizedYearTwo
1446000
CY2013 bcrx Defined Contribution Plan Employer Matching Contribution Amount
DefinedContributionPlanEmployerMatchingContributionAmount
313000
CY2013 bcrx Share Based Compensation Arrangement By Share Based Payment Award Restricted Options Granted Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedOptionsGrantedOutstanding
shares
CY2013 bcrx Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Awards Available
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAwardsAvailable
3277000 shares
CY2013 bcrx Currency Hedge Agreement Termination Period Maximum
CurrencyHedgeAgreementTerminationPeriodMaximum
2020
CY2013 bcrx Foreign Currency Hedge Termination Maximum Obligation
ForeignCurrencyHedgeTerminationMaximumObligation
5850000
CY2013 bcrx Deferred Collaboration Expense Changes In Operating Assets And Liabilities
DeferredCollaborationExpenseChangesInOperatingAssetsAndLiabilities
-5133000
CY2013 bcrx Redemption In Percentage Thereafter
RedemptionInPercentageThereafter
1.000 pure
CY2012 us-gaap Increase Decrease In Derivative Assets
IncreaseDecreaseInDerivativeAssets
-749000
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
539000
CY2012 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
16153000
CY2013 bcrx Income Tax Reconciliation Income Tax Expense Benefit Expiration Of Carryforwards
IncomeTaxReconciliationIncomeTaxExpenseBenefitExpirationOfCarryforwards
242000
CY2013 bcrx Income Tax Reconciliation State And Local Income Taxes Net Of Federal Tax Benefit
IncomeTaxReconciliationStateAndLocalIncomeTaxesNetOfFederalTaxBenefit
-839000
CY2013 bcrx Lease Hold Improvements Amortization Description
LeaseHoldImprovementsAmortizationDescription
Leasehold improvements are amortized over their estimated useful lives or the remaining lease term, whichever is less.
CY2013 bcrx Operating Loss Carry Forwards Expiration Ending Year
OperatingLossCarryForwardsExpirationEndingYear
2033
CY2013 bcrx Operating Loss Carry Forwards Expiration Starting Year
OperatingLossCarryForwardsExpirationStartingYear
2014
CY2013 bcrx Share Based Compensation Arranged By Share Based Payment Award Stock Option Award Pro Rata Vesting Period
ShareBasedCompensationArrangedByShareBasedPaymentAwardStockOptionAwardProRataVestingPeriod
P3Y
CY2013 bcrx Proceeds From Payments For Foreign Currency Derivative Collateral
ProceedsFromPaymentsForForeignCurrencyDerivativeCollateral
5180000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
86000 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
415000 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009 pure
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.87 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.26
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1617000 shares
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y4M24D
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.65
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.24
CY2012 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
110000 shares
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.58
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
348000 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
1052000 shares
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1026000 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Other Share Increase Decrease
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease
1700000 shares
CY2012 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4774000 shares
CY2012 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-33888000
CY2012 us-gaap Interest And Other Income
InterestAndOtherIncome
222000
CY2012 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
829000
CY2012 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-1269000
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-39081000
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-263000
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13000
CY2012 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
321000
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4167000
CY2012 us-gaap Royalty Revenue
RoyaltyRevenue
3317000
CY2012 us-gaap Payments For Restructuring
PaymentsForRestructuring
58000
CY2012 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-749000
CY2012 us-gaap Sales Revenue Net
SalesRevenueNet
26293000
CY2012 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
18807000
CY2012 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
113000
CY2012 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-317000
CY2012 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-13000
CY2012 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
17805000
CY2012 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2068000
CY2012 us-gaap Costs And Expenses
CostsAndExpenses
60181000
CY2012 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6826000
CY2012Q1 us-gaap Sales Revenue Net
SalesRevenueNet
12221000
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.25
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-12276000
CY2012Q2 us-gaap Sales Revenue Net
SalesRevenueNet
4210000
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
16960000
CY2012 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
7002000
CY2012 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
321000
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-9577000
CY2012 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
4167000
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
4167000
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4447000
CY2012 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
629000
CY2012 us-gaap Interest Expense
InterestExpense
4666000
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
17805000
CY2012 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-13678000
CY2012 us-gaap Royalty Expense
RoyaltyExpense
132000
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
24884000
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
51464000
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
534000
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
628000
CY2012 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
439000
CY2012 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
40833000
CY2012 us-gaap Restructuring Charges
RestructuringCharges
1759000
CY2012 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
1147000
CY2012 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
281000
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2012 bcrx Weighted Average Shares Outstanding
WeightedAverageSharesOutstanding
49474000 shares
CY2012 bcrx Share Based Compensation Arrangement By Share Based Payment Award Restricted Options Cancelled Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedOptionsCancelledOutstanding
shares
CY2012 bcrx Income Tax Reconciliation Income Tax Expense Benefit For Permanent Items
IncomeTaxReconciliationIncomeTaxExpenseBenefitForPermanentItems
754000
CY2012 bcrx Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Awards Available
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodAwardsAvailable
1052000 shares
CY2012 bcrx Share Based Compensation Arrangement By Share Based Payment Award Option Exercised Award Available
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisedAwardAvailable
shares
CY2012 bcrx Share Based Compensation Arrangement By Share Based Payment Award Restricted Options Cancelled Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedOptionsCancelledWeightedAverageExercisePrice
CY2012 bcrx Share Based Compensation Arrangement By Share Based Payment Award Restricted Options Granted Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedOptionsGrantedWeightedAverageExercisePrice
CY2012 bcrx Collaborative And Other Research And Development
CollaborativeAndOtherResearchAndDevelopment
22976000
CY2012 bcrx Defined Contribution Plan Employer Matching Contribution Amount
DefinedContributionPlanEmployerMatchingContributionAmount
418000
CY2012 bcrx Share Based Compensation Arrangement By Share Based Payment Award Restricted Options Granted Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedOptionsGrantedOutstanding
shares
CY2012 bcrx Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Awards Available
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodAwardsAvailable
1617000 shares
CY2012 bcrx Deferred Collaboration Expense Changes In Operating Assets And Liabilities
DeferredCollaborationExpenseChangesInOperatingAssetsAndLiabilities
-2301000
CY2012 bcrx Income Tax Reconciliation Income Tax Expense Benefit Expiration Of Carryforwards
IncomeTaxReconciliationIncomeTaxExpenseBenefitExpirationOfCarryforwards
5135000
CY2012 bcrx Income Tax Reconciliation State And Local Income Taxes Net Of Federal Tax Benefit
IncomeTaxReconciliationStateAndLocalIncomeTaxesNetOfFederalTaxBenefit
-1470000
CY2012 bcrx Proceeds From Payments For Foreign Currency Derivative Collateral
ProceedsFromPaymentsForForeignCurrencyDerivativeCollateral
-1700000
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-4506000
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
3554000
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-6052000
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-11053000
CY2012Q4 us-gaap Sales Revenue Net
SalesRevenueNet
4101000
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-5429000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-12172000
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
821000
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-9700000
CY2012Q3 us-gaap Sales Revenue Net
SalesRevenueNet
5761000
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-8001000
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
2389000
CY2012Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2013Q4 us-gaap Sales Revenue Net
SalesRevenueNet
10567000

Files In Submission

Name View Source Status
0001193125-14-091609-index-headers.html Edgar Link pending
0001193125-14-091609-index.html Edgar Link pending
0001193125-14-091609.txt Edgar Link pending
0001193125-14-091609-xbrl.zip Edgar Link pending
bcrx-20131231.xml Edgar Link completed
bcrx-20131231.xsd Edgar Link pending
bcrx-20131231_cal.xml Edgar Link unprocessable
bcrx-20131231_def.xml Edgar Link unprocessable
bcrx-20131231_lab.xml Edgar Link unprocessable
bcrx-20131231_pre.xml Edgar Link unprocessable
d668682d10k.htm Edgar Link pending
d668682dex1010.htm Edgar Link pending
d668682dex1011.htm Edgar Link pending
d668682dex1023.htm Edgar Link pending
d668682dex1051.htm Edgar Link pending
d668682dex1052.htm Edgar Link pending
d668682dex21.htm Edgar Link pending
d668682dex23.htm Edgar Link pending
d668682dex311.htm Edgar Link pending
d668682dex312.htm Edgar Link pending
d668682dex321.htm Edgar Link pending
d668682dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g668682ex10_23pg01.jpg Edgar Link pending
g668682ex10_51pg01.jpg Edgar Link pending
g668682g65e75.jpg Edgar Link pending
g668682im2.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending